Arteriosclerosis and Thrombosis, Vol 13, 338-346, Copyright © 1993 by American Heart Association

ARTICLES

Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon

E Tremoli, M Camera, P Maderna, L Sironi, L Prati, S Colli, F Piovella, F Bernini, A Corsini and L Mussoni
Institute of Pharmacological Sciences, University of Milan, Italy.

The effects of native and acetylated low density lipoproteins (LDLs and acetyl-LDLs, respectively) on the release of plasminogen activator inhibitor type 1 (PAI-1) by cultured human umbilical vein endothelial cells (ECs) were evaluated. LDL and acetyl-LDL incubated with ECs for 16-18 hours increased the PAI-1 antigen levels in conditioned medium. At a concentration of 100 micrograms/mL, LDL and acetyl-LDL increased PAI-1 by 10.8 and 12.0 ng/mL, respectively (p < 0.05 and p < 0.01 versus control). The increases in PAI-1 antigen levels exerted by the lipoproteins paralleled the changes in PAI-1 activity. The effect of LDL and acetyl-LDL was concentration dependent and specific for PAI-1 because tissue-type plasminogen activator and expression of procoagulant activity were not affected by either lipoprotein. In addition, total protein synthesis evaluated in [35S] methionine-labeled ECs was not affected, and studies with cycloheximide showed that the effect of LDL and acetyl-LDL on PAI-1 release was due to de novo protein synthesis. Experiments using the C7 monoclonal antibody against the LDL receptor and binding-defective LDL indicated that the effect of LDL on the synthesis of PAI-1 was not dependent on the interaction of the LDLs with their specific receptors. Finally, extensive oxidation of LDL prevented and even reversed the effect of LDL on PAI-1 release by ECs. It is concluded that LDL specifically increases the synthesis of PAI-1 by ECs with mechanisms that are not receptor mediated.

This article has been cited by other articles:

				G. V. Sangle, R. Zhao, and G. X. Shen Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1243 - E1254. [Abstract] [Full Text] [PDF]

				S. Eligini, S. Stella Barbieri, V. Cavalca, M. Camera, M. Brambilla, M. De Franceschi, E. Tremoli, and S. Colli Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-{alpha} and phorbol ester in human endothelial cells Cardiovasc Res, February 15, 2005; 65(3): 683 - 693. [Abstract] [Full Text] [PDF]

				Conxita De Castellarnau, J. L. Sanchez-Quesada, S. Benitez, R. Rosa, L. Caveda, L. Vila, and J. Ordonez-Llanos Electronegative LDL From Normolipemic Subjects Induces IL-8 and Monocyte Chemotactic Protein Secretion by Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20(10): 2281 - 2287. [Abstract] [Full Text] [PDF]

				E. M. Tabengwa, R. L. Benza, H. E. Grenett, and F. M. Booyse Hypertriglyceridemic VLDL Downregulates Tissue Plasminogen Activator Gene Transcription Through cis-Repressive Region(s) in the Tissue Plasminogen Activator Promoter in Cultured Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1675 - 1681. [Abstract] [Full Text] [PDF]

				S. Ren and G. X. Shen Impact of Antioxidants and HDL on Glycated LDL-Induced Generation of Fibrinolytic Regulators From Vascular Endothelial Cells Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1688 - 1693. [Abstract] [Full Text] [PDF]

				S. Ren, S. Shatadal, and G. X. Shen Protein kinase C-beta mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells Am J Physiol Endocrinol Metab, April 1, 2000; 278(4): E656 - E662. [Abstract] [Full Text] [PDF]

				W. Dichtl, A. Stiko, P. Eriksson, I. Goncalves, F. Calara, C. Banfi, M. P. S. Ares, A. Hamsten, and J. Nilsson Oxidized LDL and Lysophosphatidylcholine Stimulate Plasminogen Activator Inhibitor-1 Expression in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 3025 - 3032. [Abstract] [Full Text] [PDF]

				S. Eligini, S. Colli, F. Basso, L. Sironi, and E. Tremoli Oxidized Low Density Lipoprotein Suppresses Expression of Inducible Cyclooxygenase in Human Macrophages Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1719 - 1725. [Abstract] [Full Text] [PDF]

				M. A. van den Dorpel, A. J. M. i.'t Veld, M. Levi, J. W. ten Cate, and W. Weimar Beneficial Effects of Conversion From Cyclosporine to Azathioprine on Fibrinolysis in Renal Transplant Recipients Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1555 - 1558. [Abstract] [Full Text] [PDF]

				B. A. Allison, L. Nilsson, F. Karpe, A. Hamsten, and P. Eriksson Effects of Native, Triglyceride-Enriched, and Oxidatively Modified LDL on Plasminogen Activator Inhibitor-1 Expression in Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1354 - 1360. [Abstract] [Full Text] [PDF]

				M. Camera, P. L. A. Giesen, J. Fallon, B. M. Aufiero, M. Taubman, E. Tremoli, and Y. Nemerson Cooperation Between VEGF and TNF-{alpha} Is Necessary for Exposure of Active Tissue Factor on the Surface of Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 531 - 537. [Abstract] [Full Text] [PDF]

				A. Festa, R. D'Agostino Jr, L. Mykkanen, R. Tracy, B. V. Howard, and S. M. Haffner Low-Density Lipoprotein Particle Size Is Inversely Related to Plasminogen Activator Inhibitor-1 Levels : The Insulin Resistance Atherosclerosis Study Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 605 - 610. [Abstract] [Full Text] [PDF]

				L. Nilsson, C. Banfi, U. Diczfalusy, E. Tremoli, A. Hamsten, and P. Eriksson Unsaturated Fatty Acids Increase Plasminogen Activator Inhibitor-1 Expression in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1679 - 1685. [Abstract] [Full Text] [PDF]

				J. Zhang, S. Ren, D. Sun, and G. X. Shen Influence of Glycation on LDL-Induced Generation of Fibrinolytic Regulators in Vascular Endothelial Cells Arterioscler. Thromb. Vasc. Biol., July 1, 1998; 18(7): 1140 - 1148. [Abstract] [Full Text] [PDF]

				D. M. Smalley, N. Hogg, B. Kalyanaraman, and K. A. Pritchard Jr Endothelial Cells Prevent Accumulation of Lipid Hydroperoxides in Low-Density Lipoprotein Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3469 - 3474. [Abstract] [Full Text]

				S. Colli, S. Eligini, M. Lalli, M. Camera, R. Paoletti, and E. Tremoli Vastatins Inhibit Tissue Factor in Cultured Human Macrophages: A Novel Mechanism of Protection Against Atherothrombosis Arterioscler. Thromb. Vasc. Biol., February 1, 1997; 17(2): 265 - 272. [Abstract] [Full Text]

				L. Sironi, L. Mussoni, L. Prati, D. Baldassarre, M. Camera, C. Banfi, and E. Tremoli Plasminogen Activator Inhibitor Type-1 Synthesis and mRNA Expression in HepG2 Cells Are Regulated by VLDL Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 89 - 96. [Abstract] [Full Text]

				H. Haller, D. Schaper, W. Ziegler, S. Philipp, M. Kuhlmann, A. Distler, and F. C. Luft Low-Density Lipoprotein Induces Vascular Adhesion Molecule Expression on Human Endothelial Cells Hypertension, April 1, 1995; 25(4): 511 - 516. [Abstract] [Full Text]